Clinical Trial

Iliac Stent-Grafts in TASC C-D Lesions

Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
This study aims to evaluate the midterm outcomes of patients with advanced aortoiliac artery narrowing (TASC C-D lesions) who were treated with covered iliac stent-grafts instead of open surgery. These patients were either too high-risk for surgery or refused it. Medical records from the past five years at a single cardiovascular surgery center in Turkey were reviewed retrospectively. The research focuses on the success rate of the procedure, complications, vessel patency, and the need for additional treatments. The results may help guide treatment decisions in similar high-risk patients who are not candidates for open vascular surgery.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-06-24.
Trial Details
NCT Number NCT07048925
Lead Sponsor Samsun University
Conditions Aortoiliac Occlusive Disease, Endovascular Treatments, Peripheral Arterial Disease(PAD)
Enrollment 52 participants
Start Date 2024-01-01
Primary Completion 2025-01-01 (estimated)
Study Completion 2025-08-30 (estimated)
Updated on ClinicalTrials.gov 2025-07-20